APA

Gardin A., Gray C., Neelakantham S., Huth F., Davidson A. M., Dumitras S., Legangneux E. & Shakeri-Nejad K. (20190308). Siponimod pharmacokinetics, safety, and tolerability in combination with rifampin, a CYP2C9/3A4 inducer, in healthy subjects. : European journal of clinical pharmacology.

Chicago

Gardin Anne, Gray Cathy, Neelakantham Srikanth, Huth Felix, Davidson Antonia M, Dumitras Swati, Legangneux Eric and Shakeri-Nejad Kasra. 20190308. Siponimod pharmacokinetics, safety, and tolerability in combination with rifampin, a CYP2C9/3A4 inducer, in healthy subjects. : European journal of clinical pharmacology.

Harvard

Gardin A., Gray C., Neelakantham S., Huth F., Davidson A. M., Dumitras S., Legangneux E. and Shakeri-Nejad K. (20190308). Siponimod pharmacokinetics, safety, and tolerability in combination with rifampin, a CYP2C9/3A4 inducer, in healthy subjects. : European journal of clinical pharmacology.

MLA

Gardin Anne, Gray Cathy, Neelakantham Srikanth, Huth Felix, Davidson Antonia M, Dumitras Swati, Legangneux Eric and Shakeri-Nejad Kasra. Siponimod pharmacokinetics, safety, and tolerability in combination with rifampin, a CYP2C9/3A4 inducer, in healthy subjects. : European journal of clinical pharmacology. 20190308.